Newly added drugs in national reimbursement drug list
Total count of new drug varieties incorporated into a national reimbursement drug list during a catalog adjustment cycle.
Unit Count Industry Pharmaceuticals
The chart
Over time
China over time. Forecasts are dashed with hollow markers; the underlying values are one click away under the chart.
Newly added drugs in national reimbursement drug list
China, as of 28 Nov 2024 to as of 7 Dec 2025
View the underlying data
| Period | Type | Value |
|---|---|---|
| as of 28 Nov 2024 | Actual | 91 |
| as of 7 Dec 2025 | Actual | 114 |
Every record
All records
3 records · 1 region · 2024–2025
| Period | Value | Source | Type |
|---|---|---|---|
| China 3 records | |||
| as of 7 Dec 2025 | 114 | SCIO · 7 Dec 2025 | actual |
| as of 7 Dec 2025 | 114 | State Council · 7 Dec 2025 | actual |
| as of 28 Nov 2024 | 91 | NHSA · 28 Nov 2024 | actual |
Primary documents
Sources
3 documents. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| 国家医疗保障局 医保动态 国家医保局 人力资源社会保障部印发2024年版国家医保药品目录 | NHSA | 28 Nov 2024 | 1 |
| China updates national medical insurance catalog, adds 114 new drugs | SCIO | — | 1 |
| China updates national medical insurance catalog, adds 114 new drugs | State Council | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Newly added drugs in national reimbursement drug list. Retrieved from https://statorigin.org/indicators/newly-added-drugs-in-national-reimbursement-drug-list